Resonac Holdings Corporation · TSE:4004
Resonac — Q3 2025 Earnings Presentation
25 slides from Resonac's earnings presentation, Nov 13, 2025
Slide 1: Consolidated Financial Results Third Quarter, 2025
Consolidated Financial Results Third Quarter, 2025 Hideki Somemiya, CFO Director & Managing Corporate Officer November 13, 2025
Slide 2: Key Takeaways
Key Takeaways Core operating profit in the Semiconductor and 01 Electronic Materials segment reached a record high on a quarterly basis Core operating profit increased compared to 2024 1–3Q 02 - driven by the strong performance of the Semiconductor and Electronic Materials segment, which offset the
Slide 3: Summary (2024 1-3Q vs. 2025 1-3Q)
Summary (2024 1-3Q vs. 2025 1-3Q) IFRS (Unit: Billions of Yen) 2024 2025 Increase/ Without Crasus Chemical (Olefins & Derivatives) 1-3Q*1 1-3Q Decrease 2024 2025 Increase/ 1-3Q*1 1-3Q Decrease Revenue 1,029.3 986.3 (43.0) Revenue 786.8 763.5 (23.3) Core operating profit 68.8 72.8 4.0 Core operating
Slide 4: Breakdown of Core Operating Profit Changes
Breakdown of Core Operating Profit Changes (2024 1-3Q vs. 2025 1-3Q) Mobility +3.5 Chemicals (6.9) (Unit: Billions of Yen) Semiconductor & Crasus Chemical (21.6) Electronic Materials +16.5 Mobility (4.4) Semiconductor & 90.0 Semiconductor & Electronic Materials +6.5 Electronic Materials (5.1) Crasus
Slide 5: Breakdown of Segment Core Operating Profit Changes
Breakdown of Segment Core Operating Profit Changes (2024 1-3Q vs. 2025 1-3Q) Semiconductor & Electronic Materials (bn¥) 90.0 80.0 6.5 74.0 16.5 3.3 70.0 60.0 (5.1) 52.8 50.0 40.0 30.0 20.0 10.0 0.0 2024 1-3Q*1 Sales volume Sales price Variable/Fixed cost Others 2025 1-3Q Mobility*2 (bn¥) 10.0 5.0 3.
Slide 6: Breakdown of Segment Core Operating Profit Changes
Breakdown of Segment Core Operating Profit Changes (2024 1-3Q vs. 2025 1-3Q) Innovation Enabling Materials (bn¥) 15.0 10.0 8.8 2.6 8.1 5.0 (1.6) (1.3) (0.4) 0.0 2024 1-3Q*1 Sales volume Sales price Variable/Fixed cost Others 2025 1-3Q Chemicals*2 (bn¥) 5.0 1.8 0.0 (2.7) (5.0) 2.0 (10.0) (6.9) (7.4)
Slide 7: Revenue, Core Operating Profit and EBITDA margin: Segment Breakdown
Revenue, Core Operating Profit and EBITDA margin: Segment Breakdown (2024 1-3Q vs. 2025 1-3Q) 2024 2025 (Unit: Billions of Yen) Segment Increase/Decrease 1-3Q* 1-3Q Revenue 328.5 365.7 37.2 11% Semiconductor and Core operating profit 52.8 74.0 21.2 40% Electronic Materials EBITDA margin 25.5% 29.1%
Slide 8: Revenue, Core Operating Profit and EBITDA margin: Segment Breakdown
Revenue, Core Operating Profit and EBITDA margin: Segment Breakdown 2025 (Unit: Billions of Yen) Segment 1Q 2Q 3Q Revenue 111.2 119.5 135.0 Semiconductor and Core operating profit 19.6 22.9 31.5 Electronic Materials EBITDA margin 27.1% 28.3% 31.3% Revenue 46.9 42.8 42.4 Mobility Core operating profi
Slide 9: Semiconductor and Electronic Materials
Segment Summary (2024 1-3Q vs. 2025 1-3Q) Semiconductor and Electronic Materials (Unit: Billions of Yen) 2024 2025 Increase/ Performance Overview 1-3Q* 1-3Q Decrease Both revenue and core operating profit increased, Revenue 328.5 365.7 37.2 11% thanks to the recovery in demand for semiconductors; th
Slide 10: Mobility
Segment Summary (2024 1-3Q vs. 2025 1-3Q) Mobility (Unit: Billions of Yen) 2024 2025 Increase/ Performance Overview 1-3Q* 1-3Q Decrease Revenue 149.7 132.1 (17.6) (12%) Both revenue and core operating profit decreased, due to the divestiture of secondary Core operating profit 3.9 2.0 (1.9) (48%) bat
Slide 11: Innovation Enabling Materials
Segment Summary (2024 1-3Q vs. 2025 1-3Q) Innovation Enabling Materials (Unit: Billions of Yen) 2024 2025 Increase/ Performance Overview 1-3Q* 1-3Q Decrease Revenue 71.6 67.9 (3.6) (5%) Core operating profit 8.8 8.1 (0.7) (8%) Both revenue and core operating profit decreased due to lower demand for
Slide 12: Chemicals
Segment Summary (2024 1-3Q vs. 2025 1-3Q) Chemicals (Unit: Billions of Yen) 2024 2025 Increase/ Performance Overview 1-3Q* 1-3Q Decrease Revenue 150.8 125.9 (24.9) (17%) - Basic Chemicals: Both revenue and core operating profit increased due to higher Basic Chemicals 63.6 64.9 1.3 2% volume of carbo
Slide 13: Crasus Chemical
Segment Summary (2024 1-3Q vs. 2025 1-3Q) Crasus Chemical (Unit: Billions of Yen) 2024 2025 Increase/ Performance Overview 1-3Q* 1-3Q Decrease Revenue 242.5 222.8 (19.7) (8%) Revenue decreased due to the lower selling Core operating profit 5.1 3.3 (1.8) (35%) prices following the drop in naphtha pri
Slide 14: Non-recurring Items/Financial Income/Costs, Equity in Earnings
Non-recurring Items/Financial Income/Costs, Equity in Earnings Non-recurring Items (Unit: Billions of Yen) Financial Income/Costs, Equity in Earnings (Unit: Billions of Yen) 2024 2025 Increase/ 2024 2025 Increase/ 1-3Q*1 1-3Q Decrease 1-3Q*1 1-3Q Decrease Gain on sale of non- Interest and dividend c
Slide 15: Consolidated Balance Sheet
Consolidated Balance Sheet Consolidated Statement of Financial Position (Unit: Billions of Yen) Dec. 31, Sep. 30, Increase/ Dec. 31, Sep. 30, Increase/ Assets 2024*1 2025 Decrease Liabilities and equity 2024*1 2025 Decrease Cash and cash equivalents 294.7 216.3 (78.4) Trade payables 171.4 146.5 (24.
Slide 16: Appendix
Appendix ©Resonac Holdings Corporation All Rights Reserved.
Slide 17: Subsidiaries and Associates, Key Outside Factors
Reference Subsidiaries and Associates, Key Outside Factors Subsidiaries and Associates Subsidiaries: 112 (-11 from Dec. 31, 2024) -8: Related to the transfer of regenerative medicine business, secondary battery packaging materials and food packaging materials business, etc. -2: Related to the liquid
Slide 18: Capital Expenditures: Segment Breakdown
Reference Capital Expenditures: Segment Breakdown (Unit: Billions of Yen) Increase/ Segment 2024 1-3Q* 2025 1-3Q Decrease Semiconductor and Electronic Materials 34.1 53.6 19.5 Mobility 7.9 7.2 (0.7) Innovation Enabling Materials 3.7 3.8 0.1 Chemicals 11.7 13.4 1.7 Crasus Chemical (Olefins & Derivati
Slide 19: Depreciation: Segment Breakdown
Reference Depreciation: Segment Breakdown (Unit: Billions of Yen) 2024 2025 Increase/ Segment 1-3Q* 1-3Q Decrease Depreciation and amortization (excl. PPA) 21.6 23.0 1.3 Semiconductor and PPA depreciation 9.3 9.3 - Electronic Materials Total depreciation and amortization 30.9 32.3 1.3 Depreciation a
Slide 20: Summary (2025 2Q vs. 2025 3Q)
Reference Summary (2025 2Q vs. 2025 3Q) (Unit: Billions of Yen) 2025 2025 Increase/ 2Q 3Q Decrease Revenue 320.9 344.2 23.3 Core operating profit 19.8 38.2 18.5 Non-recurring items (1.1) (49.4) (48.3) Operating profit (IFRS) 18.6 (11.1) (29.8) Financial income/costs, Equity in earnings (0.7) 0.9 1.6
Slide 21: 2024 Revenue, Core Operating Profit and EBITDA margin: Segment Breakdown
Reference 2024 Revenue, Core Operating Profit and EBITDA margin: Segment Breakdown 2024* (Unit: Billions of Yen) Segment 1Q 2Q 3Q 4Q Full-year Revenue 97.5 112.1 118.9 116.7 445.1 Semiconductor and Core operating profit 8.3 18.2 26.3 20.9 73.7 Electronic Materials EBITDA margin 18.9% 25.6% 30.8% 27.
Slide 22: 2025 Consolidated Forecast, Segment Breakdown
Reference 2025 Consolidated Forecast, Segment Breakdown (Announced Feb. 13, 2025) (Unit: Billions of Yen) 2025 2025 Segment Forecast Forecast Revenue 499.0 Revenue 1,422.0 Semiconductor and Electronic Core operating profit 99.0 Materials Core operating profit 98.0 EBITDA margin 28.9% Revenue 180.0 N
Slide 23: Changes in Segmentation (From 2025)
Reference Changes in Segmentation (From 2025) Starting 2025, the segmentation has been changed as follows: Mobility segment - Automotive Products subsegment and Lithium-ion Battery Materials subsegment are consolidated and is reported as the Mobility segment due to the portfolio restructuring - Anod
Slide 24: Topics
Reference Topics Segment Topics Semiconductor Resonac Launches 27-Member "JOINT3" Consortium to Develop Next-Generation and Electronic Materials Semiconductor Packaging Notice Regarding the Transfer of Automotive Molded Parts Business in Japan and Mobility Thailand Through Absorption-Type Company Sp
Slide 25: Note
Note Performance forecast and other statements pertaining to the future as contained in this presentation are based on the information available as of today and assumptions as of today regarding risk factors that could affect our future performance. Actual results may differ materially from the fore